馃嚛馃嚢 Novo Nordisk A/S
NOVO-B.COFundamentals
Gross Margin
81.0%
Op. Margin
41.3%
Net Margin
33.1%
ROIC
35.9%
Rev Growth
6.4%
Valuation
Price
298.95 DKK
Day
+0.02%
52-Week Range
224.25 - 409.95
Market Cap
1.32T DKK
Fwd P/E
13.7x
EV/EBITDA
8.2x
Div Yield
3.88%
Annual income statement #
Novo Nordisk A/S annual revenue, operating income and net income in DKK, 2016 to 2025. Revenue was 309.06bn in 2025.
| Year | Revenue (DKK) | Operating income | Net income | Net margin |
|---|---|---|---|---|
| 2025 | 309.06bn | 127.66bn | 102.43bn | 33.1% |
| 2024 | 290.40bn | 128.34bn | 100.99bn | 34.8% |
| 2023 | 232.26bn | 102.57bn | 83.68bn | 36.0% |
| 2022 | 176.95bn | 74.81bn | 55.52bn | 31.4% |
| 2021 | 140.80bn | 58.64bn | 47.76bn | 33.9% |
| 2020 | 126.95bn | 54.13bn | 42.14bn | 33.2% |
| 2019 | 122.02bn | 52.48bn | 38.95bn | 31.9% |
| 2018 | 111.83bn | 47.25bn | 38.63bn | 34.5% |
| 2017 | 111.70bn | 48.97bn | 38.13bn | 34.1% |
| 2016 | 111.78bn | 48.43bn | 37.92bn | 33.9% |
Financial Data #
Segment Breakdown #
Short Interest #
Current: 0.20% 路
30d ago: 0.20% 路
All-time high: 0.81% (2016-11-18)
Chief Executives #
Events #
| Date | Type | Details | Price | Amount |
|---|